Palatin Technologies, Inc. (LON:0KF3)
United Kingdom · Delayed Price · Currency is GBP · Price in USD 5.84
+0.73 (14.29%)
Nov 6, 2026, 2:53 PM GMT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of 7.76 million as of November 6, 2026. It is the 41,891st most valuable company in the world and the 936th biggest in the United Kingdom. Its market cap has increased by 61.35% in one year.
Market Cap
7.76M
Enterprise Value
2.37M
Revenue
9.94M
Global Rank
Country Rank
#936 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since January 29, 2018, Palatin Technologies's market cap has decreased from 124.07M to 7.76M, a decrease of -93.74%. That is a compound annual growth rate of -27.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 7.76M | -77.92% |
| Dec 11, 2025 | 35.16M | 61.85% |
| Dec 31, 2024 | 21.72M | -43.72% |
| Dec 29, 2023 | 38.60M | 99.29% |
| Dec 28, 2022 | 19.37M | -79.00% |
| Dec 30, 2021 | 92.25M | -28.03% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 13.68M |
| SkinBioTherapeutics | 13.67M |
| Thalia Therapeutics | 10.65M |
| Genflow Biosciences | 10.20M |
| Aptamer Group | 9.34M |
| Fusion Antibodies | 7.36M |
| CRISM Therapeutics | 7.09M |
| Solvonis Therapeutics | 6.94M |